Skip to content

Tiludronic acid

Bisphosphonate — MUSCULO-SKELETAL SYSTEM

Also known as: tiludronate, tiludronate disodium

OfmFDA approvedATC M05BA05

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Tiludronic acid is an ofm drug in the Bisphosphonate class catalogued in DrugCentral. It was first approved by the FDA in 1997. DrugCentral lists 6 molecular targets, including MMP2, MMP14 and MMP8. Recorded indications include Osteitis deformans.

  • Approval status: ofm (first approved 1997 by the FDA).
  • Drug class: Bisphosphonate.
  • Molecular targets: MMP2, MMP14, MMP8 and MMP1 (6 listed in DrugCentral).
  • Indications: Osteitis deformans.
  • ATC code: M05BA05 (Bisphosphonates).
  • Molecular formula: C7H9ClO6P2S; molecular weight 318.60 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Osteitis deformans

Contraindications (21)

  • Acute nephropathy
  • Anemia
  • Aseptic necrosis of bone of jaw
  • Bed-ridden
  • Blood coagulation disorder
  • Duodenitis
  • Dysphagia
  • Esophageal dysmotility
  • Esophageal Obstruction
  • Fracture of femur
  • Gastritis
  • Hyperparathyroidism
  • Hyperphosphatemia
  • Hypocalcemia
  • Invasive Dental Procedure
  • Kidney disease
  • Peptic ulcer
  • Periodontitis
  • Primary malignant neoplasm
  • Stricture of esophagus
  • Vitamin D deficiency

Mechanism & targets

Established pharmacologic classBisphosphonate

Molecular targets (6)

TargetGeneActionActivity
72 kDa type IV collagenaseMMP2unknownIC50 5.14
Matrix metalloproteinase-14MMP14unknownIC50 4.52
Neutrophil collagenaseMMP8unknownIC50 4.49
Interstitial collagenaseMMP1unknownIC50 4.30
Tyrosine-protein phosphatase non-receptor type 1PTPN1unknown—
V-type proton ATPase 116 kDa subunit a isoform 3TCIRG1unknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1997-03-07FDA——

ATC classification

ATC codeTherapeutic hierarchy
M05BA05MUSCULO-SKELETAL SYSTEM › DRUGS FOR TREATMENT OF BONE DISEASES › DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION › Bisphosphonates

Chemical structure

Molecular formulaC7H9ClO6P2S
Molecular weight318.60 g/mol
CAS number89987-06-4
InChIKeyDKJJVAGXPKPDRL-UHFFFAOYSA-N
PubChem CID60937
OP(O)(=O)C(SC1=CC=C(Cl)C=C1)P(O)(O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Tiludronic acid used for?

DrugCentral lists the following indications for Tiludronic acid: Osteitis deformans.

How does Tiludronic acid work?

Its molecular targets in DrugCentral include MMP2, MMP14, MMP8 and MMP1.

When was Tiludronic acid first approved?

Tiludronic acid was first approved by the FDA in 1997.

What drug class does Tiludronic acid belong to?

Tiludronic acid is in the Bisphosphonate class.

What is the chemical formula of Tiludronic acid?

Tiludronic acid has the molecular formula C7H9ClO6P2S and a molecular weight of 318.60 g/mol.

Browse: all drugs starting with T · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1997-03-07
AgencyFDA
Targets6
Indications1
FormulaC7H9ClO6P2S
DrugCentral ID2666
Interactive profile